1. Home
  2. DRMA vs SNES Comparison

DRMA vs SNES Comparison

Compare DRMA & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$1.44

Market Cap

5.6M

Sector

Health Care

ML Signal

N/A

Logo SenesTech Inc.

SNES

SenesTech Inc.

N/A

Current Price

$1.28

Market Cap

6.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
DRMA
SNES
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.6M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
DRMA
SNES
Price
$1.44
$1.28
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
460.8K
93.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.99
EPS
N/A
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$29.00
Revenue Next Year
$650.00
$95.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.56
52 Week Low
$0.95
$1.15
52 Week High
$6.22
$5.15

Technical Indicators

Market Signals
Indicator
DRMA
SNES
Relative Strength Index (RSI) 55.91 44.27
Support Level $1.11 $1.15
Resistance Level $1.41 $1.81
Average True Range (ATR) 0.16 0.11
MACD 0.03 -0.00
Stochastic Oscillator 65.63 19.40

Price Performance

Historical Comparison
DRMA
SNES

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

Share on Social Networks: